Contact
Contact Dr. Kaufmann about opportunities for research collaboration or about our studies, which focus mainly on ovarian cancers and acute leukemias. We're investigating programmed cell death, cellular responses to DNA damage induced by topoisomerase poisons, development of PARP inhibitors, and cytotoxic action of novel targeted anti-cancer agents.